Aptus Capital Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $95.7K | Hold |
|
|||||
|
2025
Q2 | $83.9K | Hold |
|
|||||
|
2025
Q1 | $71.6K | Buy |
|
|||||
|
2024
Q4 | $11.5K | Sell |
|
|||||
|
2024
Q3 | $13.3K | Hold |
|
|||||
|
2024
Q2 | $12.2K | Hold |
|
|||||
|
2024
Q1 | $15K | Sell |
|
|||||
|
2023
Q4 | $17.2K | Sell |
|
|||||
|
2023
Q3 | $168K | Buy |
|
|||||
|
2023
Q2 | $196K | Sell |
|
|||||
|
2023
Q1 | $209K | Buy |
|
|||||
|
2022
Q4 | $65.2K | Buy |
|
|||||
|
2022
Q3 | $28K | Buy |
|
|||||
|
2022
Q2 | $6K | Hold |
|
|||||
|
2022
Q1 | $8K | Sell |
|
|||||
|
2021
Q4 | $29K | Sell |
|
|||||
|
2021
Q3 | $40K | Sell |
|
|||||
|
2021
Q2 | $190K | Buy |
|
|||||
|
2021
Q1 | $165K | Buy |
|
|||||
|
2020
Q4 | $117K | Buy |
|